Roche pours $190m into new diagnostics facility
This article was originally published in Clinica
Roche is to invest SwFr215m ($190m) to build a new R&D and manufacturing facility in Penzberg, Germany, for its diagnostics subsidiary. The 30,400m2 site, to be called the Diagnostics Operations Complex, will be used by the Roche Applied Science and Roche Professional Diagnostics businesses. As of mid-2010, it will manufacture products ranging from diagnostic constituents – for both the life science and immunodiagnostics markets – to whole test kits.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.